Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Glanbia plc

Consumer Defensive US GLAPF

25.68USD
0.00(0%)

Last update at 2026-06-04T15:28:00Z

Day Range

25.6825.68
LowHigh

52 Week Range

11.8920.54
LowHigh

Fundamentals

  • Previous Close 25.68
  • Market Cap4964.34M
  • Volume235
  • P/E Ratio28.53
  • Dividend Yield2.45%
  • EBITDA452.00M
  • Revenue TTM3946.40M
  • Revenue Per Share TTM15.75
  • Gross Profit TTM 1061.60M
  • Diluted EPS TTM0.72

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2023-01-31 2022-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2023-01-31 2022-12-31
Income before tax 217.65M 208.00M 392.40M 225.30M 221.71M
Minority interest - 0.00000M -0.10000M 0.80M 0.80M
Net income 190.70M 164.70M 311.96M 276.25M 253.46M
Selling general administrative 363.89M 265.20M 179.90M 212.90M 212.90M
Selling and marketing expenses 452.80M 449.90M 475.00M 415.50M 415.50M
Gross profit 1026.13M 1165.40M 1124.10M 954.50M 954.50M
Reconciled depreciation 148.80M 156.20M 149.00M 142.50M 142.50M
Ebit 365.38M 237.40M 411.60M 238.70M 267.66M
Ebitda 520.19M 336.48M 560.60M 381.20M 361.05M
Depreciation and amortization 154.81M 99.08M 149.00M 142.50M 93.39M
Non operating income net other - - - - -
Operating income 365.38M 234.70M 392.20M 223.70M 220.03M
Other operating expenses 3740.37M 3605.00M 5033.20M 5417.80M 5330.79M
Interest expense 33.08M 30.82M 19.20M 19.30M 22.48M
Tax provision 25.90M 43.30M 44.70M 25.70M 25.70M
Interest income 2.40M 5.40M 9.60M 1.70M 1.70M
Net interest income -29.40000M -26.80000M -12.50000M -20.80000M -20.80000M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 26.95M 43.30M 44.70M 25.70M 25.31M
Total revenue 4105.76M 3839.70M 5425.40M 5642.40M 5550.82M
Total operating expenses 660.75M 930.70M 731.90M 729.90M 729.90M
Cost of revenue 3079.63M 2674.30M 4301.30M 4687.90M 4687.90M
Total other income expense net -147.73398M -26.70000M 0.20M 1.60M 1.68M
Discontinued operations - - - 57.20M 57.20M
Net income from continuing ops 183.30M 164.70M 347.70M 199.60M 199.60M
Net income applicable to common shares - - - 257.60M 257.60M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2023-01-31 2022-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2023-01-31 2022-12-31
Total assets 3972.99M 3874.50M 3799.10M 3860.10M 3860.10M
Intangible assets 670.13M 770.90M 809.90M 783.80M 783.80M
Earning assets - - - - -
Other current assets 0.10M 74.80M 165.14M 17.20M 26.97M
Total liab 2046.28M 1801.70M 1666.50M 1991.70M 1991.70M
Total stockholder equity 1926.71M 2072.80M 2132.60M 1861.10M 1861.10M
Deferred long term liab - - - 22.40M 22.40M
Other current liab 106.77M 286.40M 471.30M 69.20M 460.06M
Common stock 18.40M 19.40M 19.80M 104.10M 18.96M
Capital stock 18.40M 19.40M 19.80M 104.10M 104.10M
Retained earnings 1743.15M 1775.20M 1830.80M 1397.70M 1574.74M
Other liab - - - 134.90M 134.90M
Good will 862.98M 837.10M 727.40M 668.30M 668.30M
Other assets - - -227.92361M 91.90M 91.90M
Cash 491.07M 417.00M 413.70M 438.60M 438.60M
Cash and equivalents - - - - -
Total current liabilities 1218.49M 1054.50M 880.50M 1120.00M 1120.00M
Current deferred revenue - - 60.92M - -
Net debt 722.32M 541.90M 358.10M 574.20M 622.34M
Short term debt 396.00M 321.60M 129.00M 276.00M 274.94M
Short long term debt 375.60M 300.80M 108.90M 258.20M 258.20M
Short long term debt total 1213.39M 958.90M 771.80M 1012.80M 1060.94M
Other stockholder equity 90.38M 278.20M 282.00M 359.30M 82.09M
Property plant equipment - - - 573.30M 573.30M
Total current assets 1651.88M 1487.10M 1483.10M 1551.90M 1551.90M
Long term investments - - - - -
Net tangible assets - - - 431.40M 431.40M
Short term investments - - 15.25M - 0.74M
Net receivables 497.97M 360.50M 405.89M 379.50M 335.83M
Long term debt 641.60M 552.20M 553.50M 639.80M 639.80M
Inventory 662.73M 634.80M 498.37M 703.70M 750.50M
Accounts payable 715.72M 344.60M 280.20M 774.80M 385.00M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 74.78M - 189.86M - 177.35M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 16.20M 16.69M 23.45M 278.10M 65.54M
Deferred long term asset charges - - - - -
Non current assets total 2321.11M 2387.40M 2316.00M 2308.20M 2308.20M
Capital lease obligations 108.50M 105.90M 109.40M 114.80M 114.80M
Long term debt total - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2023-01-31 2022-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2023-01-31 2022-12-31
Investments 1.80M -375.00000M 84.00M 176.70M 176.70M
Change to liabilities - - - 0.00000M 0.00000M
Total cashflows from investing activities -78.86081M -375.00000M 84.50M 176.70M 176.70M
Net borrowings 87.20M -0.50000M -130.80000M -108.90000M -108.90000M
Total cash from financing activities -314.92306M -258.40000M -396.30000M -390.20000M -390.20000M
Change to operating activities - - - 38.00M 38.00M
Net income 190.70M 164.70M 344.50M 256.80M 256.80M
Change in cash 74.32M -188.60000M 112.30M 85.90M 85.90M
Begin period cash flow 416.76M 304.80M 192.50M 94.50M 94.50M
End period cash flow 491.07M 116.20M 304.80M 180.40M 180.40M
Total cash from operating activities 396.38M 443.20M 427.80M 298.30M 298.30M
Issuance of capital stock - - - 0.00000M 0.00000M
Depreciation 154.81M 156.20M 149.00M 142.50M 142.50M
Other cashflows from investing activities - -25.10000M 223.83M -11.70000M -11.70000M
Dividends paid 122.56M 104.40M 97.20M -84.40000M 84.40M
Change to inventory -7.38670M -121.50000M 191.20M -101.10000M -101.10000M
Change to account receivables -62.94300M 116.00M -82.51838M 5.60M 5.60M
Sale purchase of stock -258.84657M -129.80000M -148.10000M -196.90000M -196.90000M
Other cashflows from financing activities -24.24086M -23.70000M -14.49594M 671.90M 671.90M
Change to netincome - - - -44.30000M -44.30000M
Capital expenditures 51.60M 87.10M 74.20M 68.90M 68.90M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -13.21283M -61.30000M -47.70000M -57.50000M -57.50000M
Stock based compensation 21.90M 18.20M 24.50M 18.80M 18.80M
Other non cash items 64.09M 165.40M -42.50000M 2.60M 2.60M
Free cash flow 344.78M 356.10M 353.60M 229.40M 229.40M

Peer Comparison

Sector: Consumer Defensive Industry: Packaged Foods

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
GLAPF
Glanbia plc		 - -% 25.68 28.53 13.83 1.26 2.58 1.40 14.30
NSRGF
Nestle SA		 -1.75 1.77% 97.00 26.86 18.76 3.13 7.10 3.81 21.70
NSRGY
Nestle SA ADR		 -0.81 0.83% 96.91 26.82 18.66 3.18 7.07 3.81 21.70
GPDNF
Danone S.A		 3.42 4.68% 76.52 25.33 17.39 1.97 2.55 1.88 11.70
DANOY
Danone PK		 -0.05 0.34% 14.84 24.23 17.64 1.88 2.57 1.88 11.70

Reports Covered

Stock Research & News

View All

Profile

Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, capsules, tablets, ready-to-eat bars, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products. In addition, the company engages in the financing business; property and land dealing business; property leasing; provision of business services and management solutions; and bioactive solutions. It offers its products under the Optimum Nutrition, BSN, Isopure, Nutramino, think!, Amazing Grass brands. The company sells its products through specialty retail, online, gym, and food, drug, mass, and club channels. Glanbia plc was founded in 1964 and is headquartered in Kilkenny, Ireland.

Glanbia plc

Leggetsrath Business Park, Kilkenny, Ireland, R95 YTD5

Key Executives

Name Title Year Born
Ms. Siobhan Talbot B.Comm, FCA Group MD & Exec. Director 1964
Mr. Mark A. Garvey Group Fin. Director & Exec. Director 1964
Mr. Brian Phelan Chief Exec. Officer of Glanbia Nutritionals 1967
Mr. Hugh McGuire Chief Exec. Officer of Glanbia Performance Nutrition 1971
Mr. Liam Hennigan Group Sec., Head of Investor Relations & Grp. Dir. of Strategic Planning and Investor Relations NA
Ms. Martha Kavanagh Head of Corp. Communications NA
Mr. Tom Tench Group Corp. Devel. Director 1971
Mr. Michael Patten Director of Group HR & Corp. Affairs 1962
Mr. Jim Bergin Chief Exec. of Glanbia Ingredients Ireland Limited 1963
Mr. Colin Gordon BBS, MBS, FMII Chief Exec. Officer of Consumer Products 1962

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.